 |
3-aminopyridine-2-carboxaldehyde thiosemicarbazone |
|---|---|
| Trade Name | Triapine |
| Orphan Indication | Stage 1B to IV cervical cancer |
| USA Market Approval | USA |
| USA Designation Date | 2017-11-08 00:00:00 |
| Sponsor | National Cancer Institute, Div of Cancer Treatment & Diagnosis (DCTD);9609 Medical Center Drive, Room 5-W520, MSC 9740;Rockville, Maryland, 20850 |
